Cargando…
GBP2 acts as a member of the interferon signalling pathway in lupus nephritis
Lupus nephritis (LN) is a common and serious clinical manifestation of systemic lupus erythematosus. However, the pathogenesis of LN is not fully understood. The currently available treatments do not cure the disease and appear to have a variety of side effects in the long term. The purpose of this...
Autores principales: | Zhang, Yuan, Liao, Yinping, Hang, Qing, Sun, Dong, Liu, Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482746/ https://www.ncbi.nlm.nih.gov/pubmed/36115937 http://dx.doi.org/10.1186/s12865-022-00520-5 |
Ejemplares similares
-
Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis
por: Wang, Xiao-dong, et al.
Publicado: (2014) -
Broad recruitment of mGBP family members to Chlamydia trachomatis inclusions
por: Lindenberg, Valesca, et al.
Publicado: (2017) -
Interferon (IFN)-λ is a potential mediator in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2016) -
Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2008) -
Murine Gbp1 and Gbp2 are ubiquitinated independent of Toxoplasma gondii infection
por: Encheva, Vesela, et al.
Publicado: (2018)